Compagnie Industrielle et Financière d'Entreprises SA
Compagnie Industrielle et Financière d'Entreprises SA (INFE.PA) Stock Competitors & Peer Comparison
See (INFE.PA) competitors and their performances in Stock Market.
Peer Comparison Table: Engineering & Construction Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| INFE.PA | €71.00 | +0.00% | 83.5M | 11.18 | €6.35 | +15.96% |
| DG.PA | €121.40 | -1.14% | 69.3B | 14.86 | €8.32 | +3.84% |
| EN.PA | €36.92 | -1.18% | 14.4B | 13.66 | €2.77 | +5.28% |
| FGR.PA | €118.85 | -1.12% | 11.2B | 11.08 | €10.93 | +3.88% |
| SPIE.PA | €51.20 | -3.12% | 8.9B | 44.38 | €1.20 | +1.88% |
| ACKB.BR | €218.00 | -1.00% | 7.2B | 15.70 | €14.04 | +1.72% |
| ARCAD.AS | €41.30 | +0.54% | 3.7B | 15.70 | €2.65 | +2.40% |
| DEME.BR | €130.60 | -0.46% | 3.3B | 13.47 | €9.80 | +2.02% |
| BAMNB.AS | €7.52 | -2.97% | 2.1B | 35.11 | €0.23 | +3.10% |
| HEIJM.AS | €59.25 | -3.74% | 1.7B | 15.18 | €4.07 | +2.65% |
Stock Comparison
INFE.PA vs DG.PA Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, DG.PA has a market cap of 69.3B. Regarding current trading prices, INFE.PA is priced at €71.00, while DG.PA trades at €121.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas DG.PA's P/E ratio is 14.86. In terms of profitability, INFE.PA's ROE is +0.30%, compared to DG.PA's ROE of +0.17%. Regarding short-term risk, INFE.PA is less volatile compared to DG.PA. This indicates potentially lower risk in terms of short-term price fluctuations for INFE.PA.Check DG.PA's competition here
INFE.PA vs EN.PA Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, EN.PA has a market cap of 14.4B. Regarding current trading prices, INFE.PA is priced at €71.00, while EN.PA trades at €36.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas EN.PA's P/E ratio is 13.66. In terms of profitability, INFE.PA's ROE is +0.30%, compared to EN.PA's ROE of +0.08%. Regarding short-term risk, INFE.PA is less volatile compared to EN.PA. This indicates potentially lower risk in terms of short-term price fluctuations for INFE.PA.Check EN.PA's competition here
INFE.PA vs FGR.PA Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, FGR.PA has a market cap of 11.2B. Regarding current trading prices, INFE.PA is priced at €71.00, while FGR.PA trades at €118.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas FGR.PA's P/E ratio is 11.08. In terms of profitability, INFE.PA's ROE is +0.30%, compared to FGR.PA's ROE of +0.16%. Regarding short-term risk, INFE.PA is less volatile compared to FGR.PA. This indicates potentially lower risk in terms of short-term price fluctuations for INFE.PA.Check FGR.PA's competition here
INFE.PA vs SPIE.PA Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, SPIE.PA has a market cap of 8.9B. Regarding current trading prices, INFE.PA is priced at €71.00, while SPIE.PA trades at €51.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas SPIE.PA's P/E ratio is 44.38. In terms of profitability, INFE.PA's ROE is +0.30%, compared to SPIE.PA's ROE of +0.14%. Regarding short-term risk, INFE.PA is less volatile compared to SPIE.PA. This indicates potentially lower risk in terms of short-term price fluctuations for INFE.PA.Check SPIE.PA's competition here
INFE.PA vs ACKB.BR Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, ACKB.BR has a market cap of 7.2B. Regarding current trading prices, INFE.PA is priced at €71.00, while ACKB.BR trades at €218.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas ACKB.BR's P/E ratio is 15.70. In terms of profitability, INFE.PA's ROE is +0.30%, compared to ACKB.BR's ROE of +0.09%. Regarding short-term risk, INFE.PA is less volatile compared to ACKB.BR. This indicates potentially lower risk in terms of short-term price fluctuations for INFE.PA.Check ACKB.BR's competition here
INFE.PA vs ARCAD.AS Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, ARCAD.AS has a market cap of 3.7B. Regarding current trading prices, INFE.PA is priced at €71.00, while ARCAD.AS trades at €41.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas ARCAD.AS's P/E ratio is 15.70. In terms of profitability, INFE.PA's ROE is +0.30%, compared to ARCAD.AS's ROE of +0.21%. Regarding short-term risk, INFE.PA is less volatile compared to ARCAD.AS. This indicates potentially lower risk in terms of short-term price fluctuations for INFE.PA.Check ARCAD.AS's competition here
INFE.PA vs DEME.BR Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, DEME.BR has a market cap of 3.3B. Regarding current trading prices, INFE.PA is priced at €71.00, while DEME.BR trades at €130.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas DEME.BR's P/E ratio is 13.47. In terms of profitability, INFE.PA's ROE is +0.30%, compared to DEME.BR's ROE of +0.14%. Regarding short-term risk, INFE.PA is less volatile compared to DEME.BR. This indicates potentially lower risk in terms of short-term price fluctuations for INFE.PA.Check DEME.BR's competition here
INFE.PA vs BAMNB.AS Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, BAMNB.AS has a market cap of 2.1B. Regarding current trading prices, INFE.PA is priced at €71.00, while BAMNB.AS trades at €7.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas BAMNB.AS's P/E ratio is 35.11. In terms of profitability, INFE.PA's ROE is +0.30%, compared to BAMNB.AS's ROE of +0.09%. Regarding short-term risk, INFE.PA is less volatile compared to BAMNB.AS. This indicates potentially lower risk in terms of short-term price fluctuations for INFE.PA.Check BAMNB.AS's competition here
INFE.PA vs HEIJM.AS Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, HEIJM.AS has a market cap of 1.7B. Regarding current trading prices, INFE.PA is priced at €71.00, while HEIJM.AS trades at €59.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas HEIJM.AS's P/E ratio is 15.18. In terms of profitability, INFE.PA's ROE is +0.30%, compared to HEIJM.AS's ROE of +0.21%. Regarding short-term risk, INFE.PA is less volatile compared to HEIJM.AS. This indicates potentially lower risk in terms of short-term price fluctuations for INFE.PA.Check HEIJM.AS's competition here
INFE.PA vs EGL.LS Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, EGL.LS has a market cap of 1.6B. Regarding current trading prices, INFE.PA is priced at €71.00, while EGL.LS trades at €4.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas EGL.LS's P/E ratio is 12.74. In terms of profitability, INFE.PA's ROE is +0.30%, compared to EGL.LS's ROE of +0.50%. Regarding short-term risk, INFE.PA is less volatile compared to EGL.LS. This indicates potentially lower risk in terms of short-term price fluctuations for INFE.PA.Check EGL.LS's competition here
INFE.PA vs ASY.PA Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, ASY.PA has a market cap of 693.7M. Regarding current trading prices, INFE.PA is priced at €71.00, while ASY.PA trades at €47.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas ASY.PA's P/E ratio is 88.80. In terms of profitability, INFE.PA's ROE is +0.30%, compared to ASY.PA's ROE of +0.03%. Regarding short-term risk, INFE.PA is less volatile compared to ASY.PA. This indicates potentially lower risk in terms of short-term price fluctuations for INFE.PA.Check ASY.PA's competition here
INFE.PA vs CFEB.BR Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, CFEB.BR has a market cap of 240.1M. Regarding current trading prices, INFE.PA is priced at €71.00, while CFEB.BR trades at €9.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas CFEB.BR's P/E ratio is 9.98. In terms of profitability, INFE.PA's ROE is +0.30%, compared to CFEB.BR's ROE of +0.10%. Regarding short-term risk, INFE.PA is less volatile compared to CFEB.BR. This indicates potentially lower risk in terms of short-term price fluctuations for INFE.PA.Check CFEB.BR's competition here
INFE.PA vs MOUR.BR Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, MOUR.BR has a market cap of 232M. Regarding current trading prices, INFE.PA is priced at €71.00, while MOUR.BR trades at €584.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas MOUR.BR's P/E ratio is 9.50. In terms of profitability, INFE.PA's ROE is +0.30%, compared to MOUR.BR's ROE of +0.20%. Regarding short-term risk, INFE.PA is less volatile compared to MOUR.BR. This indicates potentially lower risk in terms of short-term price fluctuations for INFE.PA.Check MOUR.BR's competition here
INFE.PA vs MAR.LS Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, MAR.LS has a market cap of 223M. Regarding current trading prices, INFE.PA is priced at €71.00, while MAR.LS trades at €2.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas MAR.LS's P/E ratio is 11.15. In terms of profitability, INFE.PA's ROE is +0.30%, compared to MAR.LS's ROE of +0.37%. Regarding short-term risk, INFE.PA is less volatile compared to MAR.LS. This indicates potentially lower risk in terms of short-term price fluctuations for INFE.PA.Check MAR.LS's competition here
INFE.PA vs TDSA.LS Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, TDSA.LS has a market cap of 203.3M. Regarding current trading prices, INFE.PA is priced at €71.00, while TDSA.LS trades at €0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas TDSA.LS's P/E ratio is 8.07. In terms of profitability, INFE.PA's ROE is +0.30%, compared to TDSA.LS's ROE of +0.04%. Regarding short-term risk, INFE.PA is less volatile compared to TDSA.LS. This indicates potentially lower risk in terms of short-term price fluctuations for INFE.PA.Check TDSA.LS's competition here
INFE.PA vs TVRB.PA Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, TVRB.PA has a market cap of 72.8M. Regarding current trading prices, INFE.PA is priced at €71.00, while TVRB.PA trades at €54.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas TVRB.PA's P/E ratio is 22.71. In terms of profitability, INFE.PA's ROE is +0.30%, compared to TVRB.PA's ROE of +0.01%. Regarding short-term risk, INFE.PA and TVRB.PA have similar daily volatility (0.00).Check TVRB.PA's competition here
INFE.PA vs MDF.MC Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, MDF.MC has a market cap of 49.5M. Regarding current trading prices, INFE.PA is priced at €71.00, while MDF.MC trades at €0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas MDF.MC's P/E ratio is -0.50. In terms of profitability, INFE.PA's ROE is +0.30%, compared to MDF.MC's ROE of +0.25%. Regarding short-term risk, INFE.PA is less volatile compared to MDF.MC. This indicates potentially lower risk in terms of short-term price fluctuations for INFE.PA.Check MDF.MC's competition here
INFE.PA vs CDU.LS Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, CDU.LS has a market cap of 25.4M. Regarding current trading prices, INFE.PA is priced at €71.00, while CDU.LS trades at €12.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas CDU.LS's P/E ratio is -0.77. In terms of profitability, INFE.PA's ROE is +0.30%, compared to CDU.LS's ROE of -0.17%. Regarding short-term risk, INFE.PA and CDU.LS have similar daily volatility (0.00).Check CDU.LS's competition here
INFE.PA vs MLHYE.PA Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, MLHYE.PA has a market cap of 13.2M. Regarding current trading prices, INFE.PA is priced at €71.00, while MLHYE.PA trades at €107.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas MLHYE.PA's P/E ratio is 0.47. In terms of profitability, INFE.PA's ROE is +0.30%, compared to MLHYE.PA's ROE of +0.09%. Regarding short-term risk, INFE.PA and MLHYE.PA have similar daily volatility (0.00).Check MLHYE.PA's competition here
INFE.PA vs SEC.PA Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, SEC.PA has a market cap of 4.6M. Regarding current trading prices, INFE.PA is priced at €71.00, while SEC.PA trades at €2.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas SEC.PA's P/E ratio is -101.00. In terms of profitability, INFE.PA's ROE is +0.30%, compared to SEC.PA's ROE of -0.03%. Regarding short-term risk, INFE.PA is less volatile compared to SEC.PA. This indicates potentially lower risk in terms of short-term price fluctuations for INFE.PA.Check SEC.PA's competition here
INFE.PA vs GPA.LS Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, GPA.LS has a market cap of 262.5K. Regarding current trading prices, INFE.PA is priced at €71.00, while GPA.LS trades at €0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas GPA.LS's P/E ratio is 5.25. In terms of profitability, INFE.PA's ROE is +0.30%, compared to GPA.LS's ROE of +0.00%. Regarding short-term risk, INFE.PA and GPA.LS have similar daily volatility (0.00).Check GPA.LS's competition here
INFE.PA vs MLAGI.PA Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, MLAGI.PA has a market cap of 0. Regarding current trading prices, INFE.PA is priced at €71.00, while MLAGI.PA trades at €0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas MLAGI.PA's P/E ratio is N/A. In terms of profitability, INFE.PA's ROE is +0.30%, compared to MLAGI.PA's ROE of N/A. Regarding short-term risk, INFE.PA and MLAGI.PA have similar daily volatility (0.00).Check MLAGI.PA's competition here
INFE.PA vs ORANW.AS Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, ORANW.AS has a market cap of 0. Regarding current trading prices, INFE.PA is priced at €71.00, while ORANW.AS trades at €5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas ORANW.AS's P/E ratio is -16.76. In terms of profitability, INFE.PA's ROE is +0.30%, compared to ORANW.AS's ROE of -0.01%. Regarding short-term risk, INFE.PA and ORANW.AS have similar daily volatility (0.00).Check ORANW.AS's competition here
INFE.PA vs BOKA.AS Comparison August 2025
INFE.PA plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INFE.PA stands at 83.5M. In comparison, BOKA.AS has a market cap of 0. Regarding current trading prices, INFE.PA is priced at €71.00, while BOKA.AS trades at €32.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INFE.PA currently has a P/E ratio of 11.18, whereas BOKA.AS's P/E ratio is 21.88. In terms of profitability, INFE.PA's ROE is +0.30%, compared to BOKA.AS's ROE of +0.06%. Regarding short-term risk, INFE.PA is less volatile compared to BOKA.AS. This indicates potentially lower risk in terms of short-term price fluctuations for INFE.PA.Check BOKA.AS's competition here